Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $125
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsUpgradesPrice Target
Bernstein analyst Lance Wilkes upgrades Agilon Health (NYSE:AGL) from Market Perform to Outperform and raises the price target from $86 to $125.
Bernstein analyst Lance Wilkes upgrades Agilon Health (NYSE:AGL) from Market Perform to Outperform and raises the price target from $86 to $125.